Recessive epidermolysis bullosa simplex phenotype reproduced in vitro: ablation of keratin 14 is partially compensated by keratin 17.
Recessive epidermolysis bullosa simplex (REBS) is characterized by generalized cutaneous blistering in response to mechanical trauma. This results from fragility of the basal keratinocytes that lack keratin tonofilaments because of homozygote null mutation in the keratin 14 gene. REBS patients display in addition focal dyskeratotic skin lesions with histology of epidermolytic hyperkeratosis (EHK) and tonofilament clumping in the suprabasal layers of the epidermis. In this study we examined whether it is possible to mimic in vitro the bullous and dyskeratotic cellular phenotype. For this purpose, fibroblasts from nondyskeratotic (K14-/-) and dyskeratotic (K14-/-) skin of a REBS patient and fibroblasts from a healthy donor (K14+/+) were isolated and incorporated into collagen matrices. Subsequently, fresh biopsies originating from the nondyskeratotic and dyskeratotic skin of the patient and from a healthy donor were placed onto the collagen matrices and cultured at the air-liquid interface. Epidermal morphogenesis was evaluated on the basis of tissue morphology and the expression of a series of keratins. The results of the present study indicate that basal cell vacuolization in REBS can be mimicked in vitro but not the EHK. Fibroblasts seem to play an important regulatory role in establishing the REBS phenotype. These findings suggest that wild-type fibroblasts may enhance the stability of K14-/- keratinocytes in vitro.
El Ghalbzouri
Abdoelwaheb
A
Department of Dermatology, Leiden University Medical Center, Sylvius Laboratory, 2300 RA Leiden, The Netherlands.
Jonkman
Marcel
M
Kempenaar
Johanna
J
Ponec
Maria
M
D001706:Biopsy; D018929:Cell Culture Techniques / Q000379:methods; D002478:Cells, Cultured; D004817:Epidermis / Q000473:pathology* / Q000502:physiology / Q000648:ultrastructure; D004820:Epidermolysis Bullosa / Q000235:genetics* / Q000473:pathology; D005347:Fibroblasts; D005808:Genes, Recessive; D006801:Humans; D007150:Immunohistochemistry; D053547:Keratin-14; D015603:Keratinocytes / Q000502:physiology*; D007633:Keratins / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics*; D008856:Microscopy, Fluorescence; D009154:Mutation; D010641:Phenotype
C507540:KRT14 protein, human; D053547:Keratin-14; D007633:Keratins